Founder and Clinical Director
Adrian E. Quevedo has been a leader in Quantitative EEG (qEEG) & Neurofeedback for more than a decade, having trained with some of the most respected and well known Neurofeedback pioneers such as Steve Stockdale Ph.D. and Richard Soutar Ph.D.As a Neurofeedback practitioner, Adrian has seen tremendous benefit for patients with Attention Deficit Disorder (ADD), Learning Disorders, Attention Deficit Hyperactivity Disorder (ADHD), Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), Post-Concussion Syndrome (PCS) and a wide range of behavioral and emotional disorders.Since then Adrian has owned and operated several Neurofeedback Clinics in the Orlando, Florida area. Early in his career, Adrian worked as a mental health counselor for Intervention Services, Inc. Adrian first distinguished himself in the Florida state’s attorney office (9th circuit) as a victim’s advocate counseling victims impacted by domestic violence, sex crimes and homicide.Adrian earned his Masters Degree in Counseling and Psychology from Troy State University. Yet it was at the University of Central Florida, while working on his B.A. that a Neuropsychology class exposed Adrian to the field of qEEG and Neurofeedback. This class lead him to pursue certification from the Lexicor Training Center.Connect with Adrian on LinkedIn
Creator of the New Mind Database System
A pioneer in the field of Neurofeedback, Dr. Richard Soutar has published three books on the topic of Neurofeedback and conducted workshops on the various aspects of Neurofeedback at conferences and clinics in the U.S. and Europe. As a former Professor of Psychology and Sociology, Dr. Soutar has had extensive experience in teaching and training at both the undergraduate and the graduate levels. He has also been working continuously over the years as a Clinician, Director and Business Administrator of various clinics around the country.Dr. Soutar developed the first fully certified internet training course for Neurofeedback. He has worked successfully with professional athletes and businessmen on peak performance, as well as with a wide spectrum of individuals with the traditionally labeled psychological and medical disorders. He has also pioneered a wide range of clinical screening and assessment tools for Neurofeedback including; the MiniQ, The MagnitudeAnalysis System, The Interactive Self Inventory and The NPC Symptoms Checklist. He has also consulted with a variety of equipment manufacturers on the development of The MiniQ, Distance Training, and Training Screen Formats, as well as the portable mini neurofeedback trainer, the Bioscan ABT.Presently, Dr. Soutar is consulting on a variety of grants and research projects for the development of cybernetic interface for ALS patients, Spinal Chord Injury, PTSD programs for the U.S. Military, and Industrial Design and Marketing.
Amber’s interest in neuroscience started while in a physiological psychology class her sophomore year of college. After that, she began as a teacher’s assistant for this class where she learned much more about the intricacies of the mind. This eventually led to her meeting up with Dr. Mouloua where she worked in his TRG lab at the University of Central Florida. They conducted research for his neural correlates of language experiment; working with many different languages and people. This all helped to peak her research-driven focus. She hopes to go to graduate school and gain a Ph. D. in neuropsychology.
Director of Business Development
Danny has been working within business development for nearly a decade. In that time, his work took him into multiple industries, but the bulk of his career was spent assisting hospitals and independent physician practices identify opportunities for growth. Danny understands the cost(s) of operating in the healthcare field. This is why he believes ancillary revenue is among the strongest resource for growth and development. This is because pre-existing cost are leveraged in such a way that new, unique revenue is created, without incurring any additional cost. Thus, driving the overall net revenue number that can then be reinvested into improving the patient experience, increase retention and promote market differentiation.
Danny decided to join AHPI and NewroLogix after witnessing the overwhelming outcomes Neurofeedback was providing for Adrian’s in-office patients. Being able to help make AHPI’s brand of NewroLogix Neurofeedback available to the masses, while also partnering with area physicians to help provide them with ancillary revenue, is a source of great motivation for Danny.
Director of Business Operations
Scott’s understanding, experience and success in starting, managing and growing businesses is invaluable to the organization. As Director of Business Operations, Scott helps guide the overall direction of the company and ensure consistency between the clinical and business components of AHPI and NewroLogix. Prior to joining AHPI and NewroLogix, Scott spent the bulk of his career at IBM managing some of their largest accounts, all over the world. While working with these companies, Scott helped them implement initiatives and structures that reduced cost, increased efficiency and drove productivity.
Having graduated with a Bachelor’s of Science in Applied Psychology and Industrial Factors from The Georgia Institute of Technology, Scott has a unique perspective and appreciation for technology, such as what NewroLogix provides, with regard to the improvement and development of how the brain is understood and treated. Additionally, being a dedicated father himself, he sees the value in providing families an alternative to medication whenever relevant and possible. Much like Danny, Scott is excited by the prospect of being able to help bring AHPI’s brand of NewroLogix Neurofeedback to the masses.